Filter
678
Text search:
vaccine
coverage
Featured
Recommendations
64
New Publications
169
Language
Document type
No document type
319
Studies & Reports
148
Guidelines
73
Strategic & Response Plan
53
Manuals
30
Fact sheets
24
Situation Updates
16
Resource Platforms
5
Training Material
4
Infographics
3
Brochures
2
Online Courses
1
Countries / Regions
Global
41
India
25
Kenya
20
Africa
20
Nigeria
16
Latin America and the Carribbean
16
Sierra Leone
15
Ethiopia
14
Congo, Democratic Republic of
13
Nepal
13
South Africa
13
Bangladesh
12
Liberia
11
Malawi
11
Syria
10
Uganda
9
Tanzania
9
Western and Central Europe
9
Rwanda
8
Lesotho
8
Ghana
7
Zimbabwe
7
South Sudan
7
Middle East and North Africa
7
Zambia
6
Ukraine
6
Myanmar / Burma
6
East and Southern Africa
6
West and Central Africa
6
South–East Asia Region
6
Eastern Europe
6
Philippines
5
Pakistan
5
Namibia
5
Brazil
5
Asia
5
Afghanistan
4
Guinea
3
Cambodia
3
Sudan
3
Venezuela
3
Russia
3
Senegal
2
Cameroon
2
Somalia
2
Lebanon
2
Papua New Guinea
2
Central African Republic
2
Colombia
2
Botswana
2
Chile
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Tajikistan
2
Burkina Faso
1
Mali
1
Togo
1
Haiti
1
Jordan
1
Germany
1
Chad
1
Thailand
1
Indonesia
1
Mozambique
1
Argentina
1
North Macedonia
1
Honduras
1
El Salvador
1
Angola
1
Yemen
1
Other region
1
Canada
1
Timor Leste/ East Timor
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
283
Clinical Guidelines
62
Women & Child Health
36
Public Health
35
Key Resources
35
Capacity Building
3
Pharmacy & Technologies
3
Toolboxes
COVID-19
132
HIV
40
TB
26
NTDs
23
Polio
22
Conflict
21
Rapid Response
21
AMR
20
Global Health Education
18
Ebola & Marburg
17
Health Financing Toolbox
16
Natural Hazards
14
2.0 Rapid Response
13
Planetary Health
11
Mental Health
10
Refugee
9
Cholera
8
Caregiver
7
Pharmacy
7
NCDs
4
Malaria
3
Disability
2
Zika
1
Specific Hazards
1
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
Vatican lays out 20 points for a universal and fair destination of vaccines, for a fairer and healthier world
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
Sep 22, 2021.
In our updated analysis we find that, as of September 9, there continue to be wide disparities in access and at current rates, most low-income countries (LICs) and most countries in Africa will not reach global vaccination targets. We also find that, compared to July, the rate at whic
...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si
...
Many of the countries in the European Region receiving refugees from Ukraine are already offering vaccination services to children and adults. This is important to mitigate the risk of COVID-19 transmission among people travelling or living in close quarters, to protect the refugees from diseases th
...
Mobile vaccination teams visiting long-term care homes will have an important role in providing vaccination coverage for some of the most vulnerable population sub-groups. However, based on the experiences of German mobile diagnost
...
In many countries neonatal tetanus is responsible for half of all neonatal deaths due to vaccine-preventable diseases and for almost 14% of al¡ infant deaths. It is estimated that in the 1970s more than 10,000 newborns died annually from neonatal t
...
Since May 2019, Confirmation of 4 new emergence of type 2 vaccine-derived poliovirus (VDPV2) in Bambari (2) and Bimbo (2) health districts without any genetic link between them and other known viruses ; Bambari Health District: CAF-RS4-BAM-19-058, o
...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines
...
The overall goal of this strategy is to ensure accurate understanding of the
benefits of covid-19 vaccination and alleviate apprehension about the vaccine, to ensure its acceptance and encourage uptake across various audiences.
Objectives
x Creat
...
The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. T
...
Improving the survival chances and quality of life of women, newborns, and children remains an urgent global challenge. Since 2012, substantial progress has been made in reducing maternal and under-5 deaths, and a only handful of countries are on target to meet the SDG targets in 2030. Yet, 5 millio
...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra
...
This checklist is for any organization or person supporting the routine use of evidence in
the process of policy-making. Evidence-informed policy-making (EIPM) is essential for achieving the Sustainable Development Goals (SDGs) and universal health covera
...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have ho
...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups,
...
